Monday 22 December 2014
 
»
Tag
 
»
Merck

Merck sells consumer unit to Bayer for $14bn

Merck & Co Inc has agreed to sell its consumer care business to Germany's Bayer AG for $14.2 billion, the companies said on Tuesday, adding to a string of major cross-border healthcare deals. "This acquisition marks a

More…

Merck hepatitis C drugs show promise

A two-drug combination being tested by Merck & Co to treat hepatitis C cured 98 percent of previously untreated patients without cirrhosis in a midstage clinical trial, providing the latest evidence that the US drugmaker will be highly compe

More…

Merck Serono, Neopharma in medicines deal

  Germany's Merck Serono said it would team up with an Abu Dhabi firm to produce medicines for the domestic and regional markets, the first multinational of its kind to make branded products in the UAE.  

More…

Merck, Sun Pharma set up generics JV

Helathcare leader Merck has joined hands with India's Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of innovative, branded generics in the emerging markets. The tieu

More…

Merck's new lung drug wins FDA approval

Merck & Co's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Thursday, confirming an earlier Reuters report. The inhaled treatment has been cleared for treatin

More…

Merck, Wellcome in vaccine project for poor

US drugs group Merck has teamed up with Britain's Wellcome Trust medical charity in a not-for-profit joint venture to develop affordable vaccines for poor countries. It is the first time that a drugmaker and a charity have joined forces in

More…

Merck to buy Schering-Plough for $41bn

Merck & Company said on Monday that it would acquire Schering-Plough Corp for $41.1 billion, uniting the makers of cholesterol drugs Zetia and Vytorin in the second megadeal for Big Pharma in weeks. The two New Jersey-based drugmakers,

More…

DuBiotech, Merck discuss tie-up

A high profile delegation from E. Merck OHG recently discussed potential collaborative opportunities with Dubai Biotechnology and Research Park (DuBiotech). The delegation was hosted by Dr Abdulqader Alkhayat, executive director of DuBiote

More…

Merck settles Vioxx claims for $4.85bn

Merck has agreed to pay $4.85 billion to settle US claims of heart attacks and strokes allegedly linked to its withdrawn painkiller Vioxx, the drugmaker said. The agreement was reached with law firms on the steering committee for the feder

More…

Merck says FDA approves new Aids treatment

A new Aids treatment made by Merck, the first in a new class of drugs aimed at preventing replication of the virus, has been approved by US regulators, Merck said. The drug will be available in about two weeks, Merck said. The US F

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads